Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 2
1978 8
1979 4
1980 2
1981 4
1982 1
1985 3
1986 1
1987 2
1989 1
1990 1
1991 1
1992 1
1993 1
1994 4
1995 4
1996 2
1997 2
2001 2
2002 1
2003 3
2004 3
2005 4
2006 2
2009 1
2011 3
2012 1
2015 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for thigpen t
Search for Thigpin T instead (2 results)
First-line therapy in ovarian cancer trials.
Thigpen T, duBois A, McAlpine J, DiSaia P, Fujiwara K, Hoskins W, Kristensen G, Mannel R, Markman M, Pfisterer J, Quinn M, Reed N, Swart AM, Berek J, Colombo N, Freyer G, Gallardo D, Plante M, Poveda A, Rubinstein L, Bacon M, Kitchener H, Stuart GC; Gynecologic Cancer InterGroup. Thigpen T, et al. Int J Gynecol Cancer. 2011 May;21(4):756-62. doi: 10.1097/IGC.0b013e31821ce75d. Int J Gynecol Cancer. 2011. PMID: 21543937 Review.
Maybe more is better.
Thigpen T. Thigpen T. J Clin Oncol. 2003 Jul 1;21(13):2454-6. doi: 10.1200/JCO.2003.93.115. J Clin Oncol. 2003. PMID: 12829661 No abstract available.
Chemotherapy for advanced or recurrent gynecologic cancer.
Thigpen T, Vance R, Lambuth B, Balducci L, Khansur T, Blessing J, McGehee R. Thigpen T, et al. Cancer. 1987 Oct 15;60(8 Suppl):2104-16. doi: 10.1002/1097-0142(19901015)60:8+<2104::aid-cncr2820601524>3.0.co;2-d. Cancer. 1987. PMID: 3308070 Review.
Clinical trials in ovarian carcinoma: requirements for standard approaches and regimens.
Thigpen T, Stuart G, du Bois A, Friedlander M, Fujiwara K, Guastalla JP, Kaye S, Kitchener H, Kristensen G, Mannel R, Meier W, Miller B, Poveda A, Provencher D, Stehman F, Vergote I; Gynecologic Cancer Intergroup; GOG; NCIC-CTG; AGO-OVAR; ANZGOG; JGOG; GINECO; SGCTG; MRC/NCRI; NSGO; RTOG; GEICO; EORTC. Thigpen T, et al. Ann Oncol. 2005;16 Suppl 8:viii13-viii19. doi: 10.1093/annonc/mdi962. Ann Oncol. 2005. PMID: 16239232 Free article. No abstract available.
2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference.
Stuart GC, Kitchener H, Bacon M, duBois A, Friedlander M, Ledermann J, Marth C, Thigpen T, Trimble E; participants of 4th Ovarian Cancer Consensus Conference (OCCC); Gynecologic Cancer Intergroup. Stuart GC, et al. Among authors: thigpen t. Int J Gynecol Cancer. 2011 May;21(4):750-5. doi: 10.1097/IGC.0b013e31821b2568. Int J Gynecol Cancer. 2011. PMID: 21543936 Review.
65 results